SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $0 | – | 0 | – | 0.00% | – |
Q1 2024 | $0 | – | 0 | – | 0.00% | – |
Q4 2023 | $0 | – | 0 | – | 0.00% | – |
Q3 2023 | $0 | – | 0 | – | 0.00% | – |
Q2 2023 | $0 | – | 0 | – | 0.00% | – |
Q1 2023 | $0 | – | 0 | – | 0.00% | – |
Q4 2022 | $0 | – | 0 | – | 0.00% | – |
Q3 2022 | $0 | – | 0 | – | 0.00% | – |
Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q1 2021 | $1,001,000 | -56.3% | 13,430 | 0.0% | 0.01% | -60.0% |
Q4 2020 | $2,290,000 | +34.5% | 13,430 | +10.7% | 0.02% | +15.4% |
Q3 2020 | $1,703,000 | -12.4% | 12,130 | 0.0% | 0.01% | -18.8% |
Q2 2020 | $1,945,000 | +61.7% | 12,130 | -1.4% | 0.02% | +33.3% |
Q1 2020 | $1,203,000 | -24.2% | 12,300 | 0.0% | 0.01% | -14.3% |
Q4 2019 | $1,587,000 | +71.4% | 12,300 | 0.0% | 0.01% | +55.6% |
Q3 2019 | $926,000 | – | 12,300 | – | 0.01% | – |
Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Q1 2019 | $0 | – | 0 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Q2 2018 | $0 | – | 0 | – | 0.00% | – |
Q1 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |